Pharmaceutical companies warn that new redistribution of pharmaceuticals from July will bring higher additional surcharges for patients. They note that while insurance companies will pay less, the surcharges of the patient might in some cases increase by 600%. Ministry of Health was surprised by the reaction of pharmaceutical companies.